In the Lucentis Phase III clinical trials, the most common ocular side effects included conjunctival hemorrhage, eye pain, vitreous floaters, and increased intraocular pressure. The most common ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the ...

Novartis and Roche's big-selling eye drug Lucentis has its first biosimilar competitor in Europe, after the European Commission approved Samsung Bioepis' copycat drug Byooviz.

Diabetic retinopathy affects almost 10 million people in the US and is the third FDA-approved indication for Susvimo, which is also approved for treating neovascular or ‘wet’ age-related macular ...

FDA approves RHHBY's Susvimo for diabetic retinopathy, its third indication, offering 9-month relief with one treatment.

that gives patients an alternative to regular injections into the eye. Susvimo has the same active ingredient as Roche's big-selling therapy Lucentis (ranibizumab), a VEGF inhibitor administered ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ranibizumab, is delivered through an ocular implant that is refilled every nine ...

Lead drug Eylea had global sales of just under $10 billion in 2024 and is approved for wet age-related macular degeneration and other eye-related ... regimen versus Lucentis and Avastin in ...

Many types of eye drops are available for treating dry eyes. Over-the-counter options are often effective. A doctor may recommend prescription options if they aren’t. Dry eye syndrome ...

Blue light is a high-energy light that the eyes absorb from computers, smartphones, LED lights, and fluorescent lights. The sun is the biggest source of blue light. On a sunny day, it's 100,000 ...

Dry eye syndrome can cause several side effects. Some of these can affect your vision. It’s important to seek treatment before the condition becomes severe, at which point it can cause permanent ...